[
  {
    "ts": null,
    "headline": "ResMed Inc. stock falls Thursday, underperforms market",
    "summary": "ResMed Inc. stock falls Thursday, underperforms market",
    "url": "https://finnhub.io/api/news?id=28882e7a48234b31cb5bdcc39b2c9eb09e70f9e43f994ef5eef82fc0e37d1fee",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733417940,
      "headline": "ResMed Inc. stock falls Thursday, underperforms market",
      "id": 131884977,
      "image": "",
      "related": "RMD",
      "source": "MarketWatch",
      "summary": "ResMed Inc. stock falls Thursday, underperforms market",
      "url": "https://finnhub.io/api/news?id=28882e7a48234b31cb5bdcc39b2c9eb09e70f9e43f994ef5eef82fc0e37d1fee"
    }
  },
  {
    "ts": null,
    "headline": "PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins",
    "summary": "Patterson Companies' overall topline in the second quarter of fiscal 2025 benefits from strength in its Animal Health segment.",
    "url": "https://finnhub.io/api/news?id=3bbdb49356f02516c6857933fb7b9a18aea616b8735bb427489c9cf9ca817eb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733414820,
      "headline": "PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins",
      "id": 131796381,
      "image": "https://media.zenfs.com/en/zacks.com/32e3eb8c0cc46c163964cde251fb4426",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Patterson Companies' overall topline in the second quarter of fiscal 2025 benefits from strength in its Animal Health segment.",
      "url": "https://finnhub.io/api/news?id=3bbdb49356f02516c6857933fb7b9a18aea616b8735bb427489c9cf9ca817eb2"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Stock Might Rise Following FDA Nod for Knee Implant Component",
    "summary": "Zimmer Biomet's Persona SoluTion Porous Plasma Spray Femur gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=dd0e79d6f373cf2e4fd5a0a6d97feb3c9e70dca7ad2fc86a80290ba004fa56c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733403060,
      "headline": "ZBH Stock Might Rise Following FDA Nod for Knee Implant Component",
      "id": 131793926,
      "image": "https://media.zenfs.com/en/zacks.com/28fc1568786cf7bd1a1b4ba4d8d32823",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Zimmer Biomet's Persona SoluTion Porous Plasma Spray Femur gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=dd0e79d6f373cf2e4fd5a0a6d97feb3c9e70dca7ad2fc86a80290ba004fa56c4"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios",
    "summary": "ResMed, Haemonetics, Phibro and Agios have been highlighted in this Industry Outlook article.",
    "url": "https://finnhub.io/api/news?id=00a1d7d5a6c00bc371525e1ec711d3d0e377690711d29b854d559bb5a0dda822",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733392800,
      "headline": "Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios",
      "id": 131792092,
      "image": "",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed, Haemonetics, Phibro and Agios have been highlighted in this Industry Outlook article.",
      "url": "https://finnhub.io/api/news?id=00a1d7d5a6c00bc371525e1ec711d3d0e377690711d29b854d559bb5a0dda822"
    }
  }
]